RAYMOND JAMES & ASSOCIATES - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 369 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,300,306
+15.8%
104,374
+49.3%
0.00%
+50.0%
Q2 2023$2,851,174
+44.6%
69,916
+32.1%
0.00%0.0%
Q1 2023$1,972,254
+167.9%
52,918
+150.8%
0.00%
+100.0%
Q4 2022$736,179
-28.2%
21,100
+15.1%
0.00%0.0%
Q3 2022$1,026,000
+45.5%
18,331
+34.6%
0.00%0.0%
Q2 2022$705,000
-31.2%
13,614
-3.4%
0.00%0.0%
Q1 2022$1,025,000
-49.7%
14,100
-18.2%
0.00%
-50.0%
Q4 2021$2,038,000
-46.1%
17,234
-38.9%
0.00%
-33.3%
Q3 2021$3,781,000
-5.0%
28,186
+14.6%
0.00%
-25.0%
Q2 2021$3,982,000
+89.2%
24,594
-6.2%
0.00%
+100.0%
Q1 2021$2,105,000
+110.9%
26,227
+42.9%
0.00%
+100.0%
Q4 2020$998,000
+282.4%
18,347
+39.7%
0.00%
Q3 2020$261,000
-29.1%
13,130
-24.9%
0.00%
Q2 2020$368,000
+61.4%
17,484
-6.1%
0.00%
Q1 2020$228,000
-14.9%
18,614
+1.9%
0.00%
Q4 2019$268,000
+12.6%
18,264
+110.2%
0.00%
Q2 2018$238,000
-9.8%
8,688
-30.6%
0.00%
Q1 2018$264,00012,5270.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders